NASDAQ:CYCC shares are up 15%

(NASDAQ:CYCC) Cyclacel Pharmaceuticals shares are up after yesterday’s earnings and a positive business update. Shares are $1.52 with more than 1.7 million in volume traded on more than 8622 trades. The companies 52 week high is $6.10 and its highest volume day this year is almost 5 million shares.

https://investor.cyclacel.com/news-releases/news-release-details/cyclacel-pharmaceuticals-reports-second-quarter-2022-financial

[mstock id=”73007″ asset=”CYCC”]

RISK: This post is the author’s view of what’s happening and is not investment advice. Use this information at your own risk as you are responsible for your trading and losses. There is no guarantee any post will be updated and should be taken on an “as is basis” when posted. The market moves and changes quickly which makes the information contained in this post old very quickly.

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.